Trial Profile
Prospective, Randomized, Open-Label Study in Patients With Mild-to-Moderate Essential Hypertension to Compare the Antihypertensive Efficacy Determined by Ambulatory Blood Pressure Monitoring of Valsartan and Enalapril After Missing One Dose
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Enalapril
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- 19 Mar 2007 Status changed from 'in progress' to 'completed'
- 04 Oct 2006 New trial record.